Convalescent plasma for people with COVID-19: a living systematic review-Reference-Cited by-同舟云学术

Convalescent plasma for people with COVID-19: a living systematic review

Published:2023-05-10 Issue:5 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Iannizzi Claire¹,Chai Khai Li²,Piechotta Vanessa³,Valk Sarah J⁴⁵,Kimber Catherine⁶,Monsef Ina³,Wood Erica M²,Lamikanra Abigail A⁷,Roberts David J⁶,McQuilten Zoe²,So-Osman Cynthia⁸⁹,Jindal Aikaj¹⁰,Cryns Nora¹,Estcourt Lise J¹¹,Kreuzberger Nina³,Skoetz Nicole³

Affiliation:

1. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne; University of Cologne; Cologne Germany

2. Transfusion Research Unit, School of Public Health and Preventive Medicine; Monash University; Melbourne Australia

3. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

4. Jon J van Rood Center for Clinical Transfusion Research; Sanquin/Leiden University Medical Center; Leiden Netherlands

5. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden Netherlands

6. Systematic Review Initiative; NHS Blood and Transplant; Oxford UK

7. Clinical, Research and Development; NHS Blood and Transplant; Oxford UK

8. Sanquin Blood Bank; Amsterdam Netherlands

9. Erasmus Medical Centre; Rotterdam Netherlands

10. Department of Transfusion Medicine; SPS Hospitals; Ludhiana (Punjab) India

11. Haematology/Transfusion Medicine; NHS Blood and Transplant; Oxford UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference471 articles.

1. Convalescent plasma in the management of moderate COVID-19 in India: an open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial);Mukherjee;medRxiv [Preprint],2020

2. Convalescent plasma in the management of moderate COVID-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID trial);Agarwal;BMJ,2020

3. Erratum: Convalescent plasma in the management of moderate COVID-19 in adults in India: Open label phase II multicentre randomised controlled trial (PLACID Trial) (The BMJ (2020) 371 (m3939) DOI: 10.1136/bmj.m3939);Agarwal;The BMJ,2020

4. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial;Alemany;Lancet Respiratory Medicine,2022

5. Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease;AlQahtani;MedRxiv [Preprint],2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness;Frontiers in Immunology;2024-09-09

2. The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity;Frontiers in Pharmacology;2024-08-01

3. Insights and innovations in Blood Transfusion;BLOOD TRANSFUS-ITALY;2024

4. Experiences in the use of multiple doses of convalescent plasma in critically ill patients with COVID‐19: An early phase 1 descriptive study;Health Science Reports;2024-03

5. Convalescent Plasma for Critically-ill Covid-19 Patients;2024-02-02